This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
5 Value Stocks With High Earnings Yield to Boost Your Portfolio
by Rimmi Singhi
Unlock your portfolio value with high earnings yield value stocks like URBN, ADNT, OVV, JAZZ and RNR that will boost your returns.
Reasons to Add RenaissanceRe (RNR) Stock to Your Portfolio
by Zacks Equity Research
An improvement in the top line led by higher premiums, fees and net investment income poises RenaissanceRe (RNR) well for growth.
RenaissanceRe (RNR) is a Top-Ranked Momentum Stock: Should You Buy?
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Buy These 4 Low-Beta Stocks to Counter Market Volatility
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. J&J Snack Foods (JJSF), Erie Indemnity (ERIE), RenaissanceRe (RNR) and Huron (HURN) are well-poised to gain.
Here's Why You Should Hold RenaissanceRe (RNR) Stock Now
by Zacks Equity Research
An improving top line, led by higher premiums, fees and net investment income, may poise RenaissanceRe (RNR) well for growth.
Why Is RenaissanceRe (RNR) Down 9.4% Since Last Earnings Report?
by Zacks Equity Research
RenaissanceRe (RNR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
5 Insurance Stocks to Buy Amid Soaring Government Bond Yields
by Nalak Das
We have narrowed our search to five insurers with strong potential for the rest of 2023. These are: AIZ, RNR, KNSL, ACGL, BRO.
Best Value Stocks to Buy for August 2nd
by Zacks Equity Research
RNR, SKX and MDC made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 2, 2023.
RenaissanceRe (RNR) Q2 Earnings Beat on Solid Investment Income
by Zacks Equity Research
RenaissanceRe's (RNR) second-quarter results benefit from improved underwriting performance, net investment income and fee income.
RenaissanceRe (RNR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for RenaissanceRe (RNR) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
RenaissanceRe (RNR) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
RenaissanceRe (RNR) delivered earnings and revenue surprises of 15.96% and 5.60%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Arch Capital Group (ACGL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Arch Capital (ACGL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
RenaissanceRe (RNR) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
RenaissanceRe (RNR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should John Hancock Multifactor Small Cap ETF (JHSC) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JHSC
Is John Hancock Multifactor Small Cap ETF (JHSC) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for JHSC
Here's Why You Should Hold RenaissanceRe (RNR) in Your Portfolio
by Zacks Equity Research
An improvement in the top line led by higher premiums, fees and net investment income should poise RenaissanceRe (RNR) well for growth.
Here's Why RenaissanceRe (RNR) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Is RenaissanceRe (RNR) Down 12.2% Since Last Earnings Report?
by Zacks Equity Research
RenaissanceRe (RNR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
RenaissanceRe (RNR) Prices Senior Notes Offering Worth $750M
by Zacks Equity Research
RenaissanceRe (RNR) intends to use the transaction proceeds primarily for financing a part of the cash consideration for the Validus acquisition.
AIG Inks Deal to Sell Validus Re, Eyes Portfolio Repositioning
by Zacks Equity Research
AIG plans to divest specific businesses within Validus Holdings to RenaissanceRe, thereby reflecting keen efforts to accelerate the growth of its core General Insurance unit.
Should John Hancock Multifactor Small Cap ETF (JHSC) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JHSC
Why RenaissanceRe (RNR) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
RenaissanceRe (RNR) Q1 Earnings Beat on Solid Property Segment
by Zacks Equity Research
RenaissanceRe's (RNR) first-quarter 2023 results indicate improved premiums earned from its segments, partly offset by an increased cost level.
RenaissanceRe (RNR) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
RenaissanceRe (RNR) delivered earnings and revenue surprises of 11.17% and 1.38%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Is John Hancock Multifactor Small Cap ETF (JHSC) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for JHSC